Synthesis and biological evaluations of pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 inhibitors
Authors:
- 1 May 2003
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 38 (5) , 525-532
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Synthesis and biological properties of C-2, C-8, N-9 substituted 6-(3-chloroanilino)-purine derivatives as cyclin-dependent kinase inhibitors. Part IIArchiv der Pharmazie, 2001
- Synthesis and activity of 2,6,9-trisubstituted purinesBioorganic & Medicinal Chemistry Letters, 1997
- Chemical inhibitors of cyclin-dependent kinasesTrends in Cell Biology, 1996
- Principles of CDK regulationNature, 1995
- Cellular effects of olomoucine, an inhibitor of cyclin‐dependent kinasesBiology of the Cell, 1995
- Inhibition of Cyclin‐Dependent Kinases by Purine AnaloguesEuropean Journal of Biochemistry, 1994
- Mammalian G1 cyclinsCell, 1993
- The Alkylation of 2-Amino-6-chloropurine with Alcohols by Mitsunobu Reaction for a Synthesis of Carbocyclic Guanosine AnalogsHETEROCYCLES, 1993
- Simple pyrimidines. Part X. The formation and reactivity of 2-, 4-, and 5-pyrimidinyl sulphones and sulphoxidesJournal of the Chemical Society C: Organic, 1967
- Potential Purine Antagonists. IX. Further Studies of Some 4,6-Disubstituted Pyrazolo[3,4-d]pyrimidines1Journal of the American Chemical Society, 1957